Patient Guide: Efficacy and safety of guselkumab in Crohn's disease (GALAXI-2): 48-week results from a phase 3 randomized, double-blind, placebo- and active-controlled, triple-dummy trial

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at multiple participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTGALAXI-2
Status: COMPLETED_NEXT_PHASE_UPCOMING
Condition: Crohn's disease
Phase: Phase III

Loading interactive enrollment tools...

The full interactive experience will load momentarily